By applying CRISPR/Cas9, mutations have been introduced to the adult mouse prostate and it was revealed that Foxp1 acts as a tumor-suppressor gene by controlling proliferation in an androgen-dependent manner. This evidence concerns the gene FOXP1 and neoplasm.